Literature DB >> 32978339

Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region.

Vineet Bhatia1, Partha Pratim Mandal1, Srinath Satyanarayana1, Tjandra Yoga Aditama1, Mukta Sharma1.   

Abstract

Almost half of the deaths worldwide caused by tuberculosis in 2018 occurred in the World Health Organization (WHO) South-East Asia Region, home to around a quarter of the global population. Maintaining robust progress in this region is therefore essential if the global goal of ending the tuberculosis epidemic is to be realized. Substantial gains have been made in the region, but the threat to health worldwide posed by the coronavirus disease 2019 (COVID-19) pandemic includes not only the direct effects of the pandemic but also the potential eclipsing of the global tuberculosis emergency. The results of modelling studies present stark warnings of a reversal of years of progress and a significant resurgence in deaths from tuberculosis. The COVID-19 pandemic has had variable impacts in the WHO South-East Asia Region to date, but in the countries most affected there has been targeted diversion and repurposing of tuberculosis services, health-care workers and diagnostic equipment. The combined effects of COVID-19, containment measures and fragmentation of tuberculosis services have resulted in delays in diagnosis or non-diagnosis and disruption in treatment resulting in increased morbidity, mortality, transmission and drug resistance. Countries of the region have made attempts to ensure continuity of services and civil society and nongovernmental organizations have instituted a range of innovative mechanisms to support national programmes. However, a comprehensive approach - including scaling up successful initiatives, empowering community leadership, harnessing digital tools, and implementing easily accessible cash transfers and nutrition support - will be critical to success. As COVID-19 recedes, countries will need "catch-up plans" to deploy supplementary measures to address the increased tuberculosis burden. Urgent, targeted and agile responses have the potential to mitigate and reverse the impact of the COVID-19 pandemic on tuberculosis in South-East Asia.

Entities:  

Keywords:  COVID-19; South-East Asia; health services; treatment; tuberculosis

Mesh:

Year:  2020        PMID: 32978339     DOI: 10.4103/2224-3151.294300

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN: 2224-3151


  8 in total

1.  TB positive cases go up in ongoing COVID-19 pandemic despite lower testing of TB: An observational study from a hospital from Northern India.

Authors:  Shruti Srivastava; Namita Jaggi
Journal:  Indian J Tuberc       Date:  2021-05-05

2.  The impact of COVID-19 on essential health service provision for endemic infectious diseases in the South-East Asia region: A systematic review.

Authors:  Laura E Downey; Thomas Gadsden; Victor Del Rio Vilas; David Peiris; Stephen Jan
Journal:  Lancet Reg Health Southeast Asia       Date:  2022-05-05

3.  The need to prioritise childhood tuberculosis case detection.

Authors:  Esin Nkereuwem; Beate Kampmann; Toyin Togun
Journal:  Lancet       Date:  2021-03-23       Impact factor: 202.731

4.  Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia.

Authors:  Dagmawi Chilot; Yimtubezinash Woldeamanuel; Tsegahun Manyazewal
Journal:  Ann Glob Health       Date:  2021-11-15       Impact factor: 2.462

5.  COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020.

Authors:  Ivan Manhiça; Orvalho Augusto; Kenneth Sherr; James Cowan; Rosa Marlene Cuco; Sãozinha Agostinho; Bachir C Macuacua; Isaías Ramiro; Naziat Carimo; Maria Benigna Matsinhe; Stephen Gloyd; Sergio Chicumbe; Raimundo Machava; Stélio Tembe; Quinhas Fernandes
Journal:  BMJ Glob Health       Date:  2022-04

Review 6.  Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.

Authors:  Stefan Baral; Amrita Rao; Jean Olivier Twahirwa Rwema; Carrie Lyons; Muge Cevik; Anna E Kågesten; Daouda Diouf; Annette H Sohn; Refilwe Nancy Phaswana-Mafuya; Adeeba Kamarulzaman; Gregorio Millett; Julia L Marcus; Sharmistha Mishra
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

7.  Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China.

Authors:  Xiaolin Wang; Wencong He; Juan Lei; Guangtian Liu; Fei Huang; Yanlin Zhao
Journal:  Front Public Health       Date:  2021-05-21

8.  Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital.

Authors:  Francesco Di Gennaro; Gina Gualano; Laura Timelli; Pietro Vittozzi; Virginia Di Bari; Raffaella Libertone; Carlotta Cerva; Luigi Pinnarelli; Carla Nisii; Stefania Ianniello; Silvia Mosti; Nazario Bevilacqua; Fabio Iacomi; Annalisa Mondi; Simone Topino; Delia Goletti; Francesco Vaia; Giuseppe Ippolito; Enrico Girardi; Fabrizio Palmieri
Journal:  Antibiotics (Basel)       Date:  2021-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.